Net shares · 365d
-362
0 buy · 362 sell
Net value · 365d
-$728
$0 in · $728 out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 362 sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
SERA Sell·S
Chief Medical Officer
$728
362 sh · $2.01
Own -0%
-
SERA Grant·A
Chief Medical Officer
$0
27.0K sh
Own New
-
SERA Grant·A
Chief Medical Officer
$0
17.4K sh
Own +23%
-
SERA Grant·A
Chief Medical Officer
$0
107.0K sh
Own New
-
SERA Grant·A
Chief Medical Officer
$0
75.0K sh
Own New
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | SERA | Sell S | 362 | $728 |
| Mar 12, 2026 | SERA | Grant A | 27.0K | $0 |
| Mar 12, 2026 | SERA | Grant A | 17.4K | $0 |
| Oct 15, 2025 | SERA | Grant A | 107.0K | $0 |
| Oct 15, 2025 | SERA | Grant A | 75.0K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About Inglis Tiffany Eul Davis
This profile aggregates every SEC Form 4 insider transaction reported by Inglis Tiffany Eul Davis across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.